Stay updated on Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    A new page revision label (Revision: v3.7.0) is added, and several sponsor/organization and document-related blocks are removed from the study record, indicating a cleanup of header and metadata rather than substantive content changes.
    Difference
    18%
    Check dated 2026-09-21T22:40:31.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This indicates an update to the study page or template version rather than to any trial content.
    Difference
    0.0%
    Check dated 2026-08-31T16:41:13.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The study record now shows the trial as Completed and adds a publication on HRQOL and symptom impact in CheckMate 9ER.
    Difference
    0.2%
    Check dated 2026-08-24T16:21:31.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, signaling a small editorial update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-08-10T10:26:03.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, signaling a minor update to the page’s documentation without changing the primary study details.
    Difference
    0.0%
    Check dated 2026-07-27T06:20:45.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    A new publication citation about the final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma has been added to the Publications section. The document revision has been updated from v3.6.2 to v3.6.3.
    Difference
    0.0%
    Check dated 2026-07-05T13:43:48.000Z thumbnail image

Stay in the know with updates to Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.